VANCOUVER, BC / ACCESS Newswire / November 25, 2025 /Variational AI, a leading innovator in generative artificial ...
Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...
Artificial intelligence (AI) is revolutionising how scientists study cancer and Type 1 diabetes and discover ways to fight them.
Explore the role of AI in drug discovery and how automation enhances precision and speed in modern scientific research.
The Chosun Ilbo on MSN
Merck Invests 4 Trillion Won in AI Drug Development Platform
German pharmaceutical company Merck (Merck) signed a contract worth 4 trillion Korean won on the 20th to adopt the AI-based new drug development platform of U.S. bio company BaloHealth. A source from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback